Biblio

Export 1218 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is W  [Clear All Filters]
2016
M. Berger, Nadler, J. W., Friedman, A., McDonagh, D. L., Bennett, E. R., Cooter, M., Qi, W., Laskowitz, D. T., Ponnusamy, V., Newman, M. F., Shaw, L. M., Warner, D. S., Mathew, J. P., and James, M. L., “The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1299-310, 2016.
G. Berge, Lauridsen, C., Sando, S. Botne, Holder, D. Joseph, Møller, I., Aasly, J. Olav, Bråthen, G., Savage, M. Josephine, and White, L. Rosemary, “Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.”, J Alzheimers Dis, vol. 49, no. 2, pp. 493-502, 2016.
J. Wang, Ye, F., Cheng, X., Zhang, X., Liu, F., Liu, G., Ni, M., Qiao, S., Zhou, W., and Zhang, Y., “The Effects of LW-AFC on Intestinal Microbiome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 907-19, 2016.
G. Liu, Weinger, J. G., Lu, Z. - L., Xue, F., and Sadeghpour, S., “Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.”, J Alzheimers Dis, vol. 49, no. 4, pp. 971-90, 2016.
H. Hochstetler, Trzepacz, P. T., Wang, S., Yu, P., Case, M., Henley, D. B., Degenhardt, E., Leoutsakos, J. - M., and Lyketsos, C. G., “Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.”, J Alzheimers Dis, vol. 50, no. 1, pp. 271-82, 2016.
M. T. White, Shaw, L. M., and Xie, S. X., “Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 463-70, 2016.
M. Varghese, Santa-Maria, I., Ho, L., Ward, L., Yemul, S., Dubner, L., Księżak-Reding, H., and Pasinetti, G. Maria, “Extracellular Tau Paired Helical Filaments Differentially Affect Tau Pathogenic Mechanisms in Mitotic and Post-Mitotic Cells: Implications for Mechanisms of Tau Propagation in the Brain.”, J Alzheimers Dis, vol. 54, no. 2, pp. 477-96, 2016.
E. D. Vidoni, Watts, A. S., Burns, J. M., Greer, C. S., Graves, R. S., Van Sciver, A., Black, J. R., Cooper, S. K., Nagely, A. C., Uphoff, E., Volmer, J. M., and Bieberle, N. A., “Feasibility of a Memory Clinic-Based Physical Activity Prescription Program.”, J Alzheimers Dis, vol. 53, no. 1, pp. 161-70, 2016.
E. H. Wilker, Martinez-Ramirez, S., Kloog, I., Schwartz, J., Mostofsky, E., Koutrakis, P., Mittleman, M. A., and Viswanathan, A., “Fine Particulate Matter, Residential Proximity to Major Roads, and Markers of Small Vessel Disease in a Memory Study Population.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1315-23, 2016.
V. C. Zimmerer, Wibrow, M., and Varley, R. A., “Formulaic Language in People with Probable Alzheimer's Disease: A Frequency-Based Approach.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1145-60, 2016.
R. Weissmann, Hüttenrauch, M., Kacprowski, T., Bouter, Y., Pradier, L., Bayer, T. A., Kuss, A. W., and Wirths, O., “Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 397-409, 2016.
R. Weissmann, Hüttenrauch, M., Kacprowski, T., Bouter, Y., Pradier, L., Bayer, T. A., Kuss, A. W., and Wirths, O., “Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 397-409, 2016.
C. - H. Andersson, Hansson, O., Minthon, L., Andreasen, N., Blennow, K., Zetterberg, H., Skoog, I., Wallin, A., Nilsson, S., and Kettunen, P., “A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1353-63, 2016.
M. Bamji-Mirza, Li, Y., Najem, D., Liu, Q. Yan, Walker, D., Lue, L. - F., Stupak, J., Chan, K., Li, J., Ghani, M., Yang, Z., Rogaeva, E., and Zhang, W., “Genetic Variations in ABCA7 Can Increase Secreted Levels of Amyloid-β40 and Amyloid-β42 Peptides and ABCA7 Transcription in Cell Culture Models.”, J Alzheimers Dis, vol. 53, no. 3, pp. 875-92, 2016.
J. Købstrup Zakarias, Jensen-Dahm, C., Nørgaard, A., Stevnsborg, L., Gasse, C., Andersen, B. Gramkow, Søren, J., Waldorff, F. Boch, Moos, T., and Waldemar, G., “Geographical Variation in Antipsychotic Drug Use in Elderly Patients with Dementia: A Nationwide Study.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1183-1192, 2016.
J. Købstrup Zakarias, Jensen-Dahm, C., Nørgaard, A., Stevnsborg, L., Gasse, C., Andersen, B. Gramkow, Søren, J., Waldorff, F. Boch, Moos, T., and Waldemar, G., “Geographical Variation in Antipsychotic Drug Use in Elderly Patients with Dementia: A Nationwide Study.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1183-1192, 2016.
J. Spiegel, Pirraglia, E., Osorio, R. S., Glodzik, L., Li, Y., Tsui, W., Louis, L. A. Saint, Randall, C., Butler, T., Xu, J., Zinkowski, R. P., Zetterberg, H., Fortea, J., Fossati, S., Wisniewski, T., Davies, P., Blennow, K., and de Leon, M. J., “Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 93-100, 2016.
S. Shi, Liang, D., Bao, M., Xie, Y., Xu, W., Wang, L., Wang, Z., and Qiao, Z., “Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways.”, J Alzheimers Dis, vol. 50, no. 3, pp. 859-71, 2016.
S. Shi, Liang, D., Bao, M., Xie, Y., Xu, W., Wang, L., Wang, Z., and Qiao, Z., “Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways.”, J Alzheimers Dis, vol. 50, no. 3, pp. 859-71, 2016.
X. Meng, Luo, Y., Liang, T., Wang, M., Zhao, J., Sun, G., and Sun, X., “Gypenoside XVII Enhances Lysosome Biogenesis and Autophagy Flux and Accelerates Autophagic Clearance of Amyloid-β through TFEB Activation.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1135-50, 2016.
E. Mead, Kestoras, D., Gibson, Y., Hamilton, L., Goodson, R., Jones, S., Eversden, S., Davies, P., O'Neill, M., Hutton, M., Szekeres, P., and Wolak, J., “Halting of Caspase Activity Protects Tau from MC1-Conformational Change and Aggregation.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1521-1538, 2016.
E. Louwersheimer, M Keulen, A., Steenwijk, M. D., Wattjes, M. P., Jiskoot, L. C., Vrenken, H., Teunissen, C. E., van Berckel, B. N. M., van der Flier, W. M., Scheltens, P., van Swieten, J. C., and Pijnenburg, Y. A. L., “Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 581-90, 2016.
Q. Hu, Teng, W., Li, J., Hao, F., and Wang, N., “Homocysteine and Alzheimer's Disease: Evidence for a Causal Link from Mendelian Randomization.”, J Alzheimers Dis, vol. 52, no. 2, pp. 747-56, 2016.
S. K. Woody, Zhou, H., Ibrahimi, S., Dong, Y., and Zhao, L., “Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1015-31, 2016.
I. Zimova, Brezovakova, V., Hromadka, T., Weisova, P., Cubinkova, V., Valachova, B., Filipcik, P., Jadhav, S., Smolek, T., Novak, M., and Zilka, N., “Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy.”, J Alzheimers Dis, vol. 54, no. 2, pp. 831-43, 2016.

Pages